Overview of amphotericin B colloidal dispersion (Amphocil)
- 31 May 1994
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 28, 45-49
- https://doi.org/10.1016/s0163-4453(94)95971-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosisAntimicrobial Agents and Chemotherapy, 1992
- Comparison of antifungal activity of amphotericin B deoxycholate suspension with that of amphotericin B cholesteryl sulfate colloidal dispersionAntimicrobial Agents and Chemotherapy, 1992
- Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogsAntimicrobial Agents and Chemotherapy, 1992
- Comparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosisAntimicrobial Agents and Chemotherapy, 1991
- Novel antifungal drug delivery: stable amphotericin B-cholesteryl sulfate discsInternational Journal of Pharmaceutics, 1991
- Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to ratsAntimicrobial Agents and Chemotherapy, 1991
- Single-dose pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin B administered to healthy volunteersAntimicrobial Agents and Chemotherapy, 1991
- Treatment of Experimental Invasive Aspergillosis with Novel Amphotericin B/Cholesterol-Sulfate ComplexesThe Journal of Infectious Diseases, 1989
- Experience with ketoconazole in three major manifestations of progressive coccidioidomycosisThe American Journal of Medicine, 1983